Clinical Management of Pancreatic Cancer
From Diagnosis to Palliative Care
- 1st Edition - May 1, 2026
- Latest edition
- Editors: Takuji Okusaka, Eileen O’Reilly
- Language: English
- Paperback ISBN:9 7 8 - 0 - 4 4 3 - 3 6 2 9 3 - 4
- eBook ISBN:9 7 8 - 0 - 4 4 3 - 3 6 2 9 2 - 7
Clinical Management of Pancreatic Cancer: From Diagnosis to Palliative Care provides comprehensive guidance and support at every step of the pancreatic cancer journey, coveri… Read more
Purchase options
Clinical Management of Pancreatic Cancer: From Diagnosis to Palliative Care provides comprehensive guidance and support at every step of the pancreatic cancer journey, covering all aspects from initial diagnosis to compassionate and holistic care, ensuring healthcare professionals have the knowledge and resources they need for effective management and improved quality of life. The book not only presents the latest advancements in pancreatic cancer management, including innovative surgical techniques, targeted therapies, radiotherapy approaches, and palliative care interventions but also focuses on maintaining and improving patients' quality of life throughout their journey, incorporating palliative medicine and supportive care to alleviate symptoms and enhance overall well-being. IN 4 sections and 29 chapters Clinical Management of Pancreatic Cancer: From Diagnosis to Palliative Care Advocates for patient-centered care by emphasizing communication, shared decision-making, and tailoring treatment approaches to individual needs and preferences. It raises awareness about pancreatic cancer, its challenges, and the importance of early detection, while also dispelling misconceptions and offering hope through informed management strategies. The book also highlights the significance of palliative medicine and comprehensive supportive care to manage symptoms, alleviate pain, and address psychosocial and emotional needs of both patients and their families. Clinical Management of Pancreatic Cancer: From Diagnosis to Palliative Care serves as a bridge between research and clinical practice, offering researchers a broader perspective and equipping clinicians with a valuable resource that enhances their knowledge, decision-making, and patient care skills in the realm of pancreatic cancer management.
- Provides the latest advancements, evidence-based approaches, and multidisciplinary insights to enhance knowledge and improve patient outcomes
- Delivers a structured and detailed overview of the clinical management of pancreatic cancer helping with the understanding of the complexities of diagnosis, treatment, and supportive care
- Facilitates collaboration among different specialists, enabling them to make informed decisions and provide well-coordinated care that addresses the various aspects of the disease
Clinicians and researchers working across the biosciences in fields of oncology
Section 1: Diagnosis
1. Risk factors for pancreatic cancer
2. Familiar risk factors and genetic testing for inherited mutation
3. Screening/surveillance in high-risk population to detect pancreatic cancer
4. Transabdominal ultrasonography for screening and diagnosis of pancreatic cancer
5. CT for diagnosis and staging of pancreatic cancer
6. MRI/MRCP for diagnosis and staging of pancreatic cancer
7. Endoscopic ultrasonography for imaging and pathological diagnosis for pancreatic cancer
8. Endoscopic retrograde cholangiopancreatography for imaging and pathological diagnosis for pancreatic cancer
9. PET/CT for diagnosis, staging and follow-up
10. Staging laparoscopy and laparoscopic ultrasound
11. Germline and tumor/somatic genomic testing
12. Staging for pancreatic cancer
Section 2: Treatments for resectable and borderline resectable pancreatic cancer
13. Neoadjuvant therapy for resectable and borderline resectable pancreatic cancer
14. Surgical resection for pancreatic cancer
15. Minimally invasive pancreatic surgery for pancreatic cancer
16. Postoperative adjuvant therapy for resectable and borderline resectable pancreatic cancer
17. Follow-up surveillance and management for patients after pancreatic surgery
Section 3: Treatments for locally advanced and metastatic pancreatic cancer
18. Treatment strategies for locally advanced pancreatic cancer
19. Chemoradiotherapy for locally advanced pancreatic cancer Gemcitabine-based chemoradiotherapy
20. First-line chemotherapy for locally advanced and metastatic pancreatic cancer
21. Second-line chemotherapy for advanced pancreatic cancer
22. Surgical resection following significant response to nonsurgical treatment for advanced pancreatic cancer
Section 4: Supportive and Palliative medicine for pancreatic cancer
23. Stents for obstructive jaundice and gastric outlet obstruction
24. Palliative surgery in advanced pancreatic cancer
25. Pain control
26. Managements for anxiety and depression
27. Advance care planning for pancreatic cancer patients
28. Venous thromboembolism in patients with pancreatic cancer
29. Managements for ascites
1. Risk factors for pancreatic cancer
2. Familiar risk factors and genetic testing for inherited mutation
3. Screening/surveillance in high-risk population to detect pancreatic cancer
4. Transabdominal ultrasonography for screening and diagnosis of pancreatic cancer
5. CT for diagnosis and staging of pancreatic cancer
6. MRI/MRCP for diagnosis and staging of pancreatic cancer
7. Endoscopic ultrasonography for imaging and pathological diagnosis for pancreatic cancer
8. Endoscopic retrograde cholangiopancreatography for imaging and pathological diagnosis for pancreatic cancer
9. PET/CT for diagnosis, staging and follow-up
10. Staging laparoscopy and laparoscopic ultrasound
11. Germline and tumor/somatic genomic testing
12. Staging for pancreatic cancer
Section 2: Treatments for resectable and borderline resectable pancreatic cancer
13. Neoadjuvant therapy for resectable and borderline resectable pancreatic cancer
14. Surgical resection for pancreatic cancer
15. Minimally invasive pancreatic surgery for pancreatic cancer
16. Postoperative adjuvant therapy for resectable and borderline resectable pancreatic cancer
17. Follow-up surveillance and management for patients after pancreatic surgery
Section 3: Treatments for locally advanced and metastatic pancreatic cancer
18. Treatment strategies for locally advanced pancreatic cancer
19. Chemoradiotherapy for locally advanced pancreatic cancer Gemcitabine-based chemoradiotherapy
20. First-line chemotherapy for locally advanced and metastatic pancreatic cancer
21. Second-line chemotherapy for advanced pancreatic cancer
22. Surgical resection following significant response to nonsurgical treatment for advanced pancreatic cancer
Section 4: Supportive and Palliative medicine for pancreatic cancer
23. Stents for obstructive jaundice and gastric outlet obstruction
24. Palliative surgery in advanced pancreatic cancer
25. Pain control
26. Managements for anxiety and depression
27. Advance care planning for pancreatic cancer patients
28. Venous thromboembolism in patients with pancreatic cancer
29. Managements for ascites
- Edition: 1
- Latest edition
- Published: May 1, 2026
- Language: English
TO
Takuji Okusaka
Takuji Okusaka is a prominent researcher known for his groundbreaking work in internal medicine, particularly in gastroenterology, hepatocellular carcinoma, oncology, and pancreatic cancer. His investigations span chemotherapy, clinical research phases, and survival rates. He explores the connections between hepatocellular carcinoma and radiology, unraveling complexities, while also delving into themes of weight loss, bioinformatics, and pancreatic diseases. With a focus on internal medicine, oncology, and gastroenterology, Okusaka's publications dominate these fields, marking him as a prolific and impactful contributor to medical research.
Affiliations and expertise
National Cancer Center, JapanEO
Eileen O’Reilly
Eileen M. O’Reilly holds the Winthrop Rockefeller Endowed Chair in Medical Oncology at Memorial Sloan Kettering Cancer Center (MSK). She serves as the Section Head for Hepatopancreaticobiliary/ Neuroendocrine Cancers, Gastrointestinal Oncology Service, Co-Director for Medical Initiatives at the David M. Rubenstein Center for Pancreatic Cancer and is an Attending Physician and Member at MSK and Professor of Medicine at Weill Cornell Medical College. Dr. O’Reilly’s other responsibilities include Chair of the Institutional Review & Privacy Board (IRB) and Chair of the Continuing Medical Education committee at MSK. Nationally, Dr. O’Reilly is Co-Chair of the NCI Alliance Co-Operative Group Gastrointestinal Cancers Committee and serves on the NCI Gastrointestinal Cancers Steering Committee (GISC) and serves in leadership roles in several advocacy organizations.
Affiliations and expertise
Memorial Sloan Kettering Cancer Center, USA